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Abstract 
Autoimmune diseases are disorders caused by a malfunction in the immune system. 
Genetic background, environmental factors and lifestyle habits have been considered as 
the factors triggering the development of these diseases. Among the environmental 
factors, viruses are one of the most important and studied causes of autoimmune 
diseases. However, even if the relationship may be clear, the mechanisms behind the 
viral infections contributing to the illness progress are not well known. Some theories 
have been suggested but more experimentation is needed to their acceptance. Type 1 
diabetes and multiple sclerosis are two examples of this type of disorders. Viral infections 
have been related to the development of multiple sclerosis and type 1 diabetes, but other 
causes may also be partially responsible. In fact, interactions and different contribution of 
these factors might finally trigger these diseases. In conclusion, evidences showed the 
association between viral infection and autoimmune diseases, but more investigation is 
needed.  
Key words 
Autoimmune diseases, environmental factor, viral infection, viruses, multiple sclerosis, 
type 1 diabetes  
 
Resumen 
Las enfermedades autoinmunes son trastornos causados por un mal funcionamiento del 
sistema inmunológico. Predisposición genética, factores ambientales y hábitos de vida se 
consideran como los factores que desencadenan el desarrollo de estas enfermedades. 
Entre los factores ambientales, los virus son una de las causas más importantes y 
estudiadas de las enfermedades autoinmunes. Sin embargo, incluso si la relación pueda 
ser clara, los mecanismos detrás de las infecciones víricas que contribuyen al progreso 
de la enfermedad aún se desconocen. Se han sugerido algunas teorías, pero se necesita 
más experimentación para que puedan ser aceptadas por la comunidad científica. La 
diabetes tipo 1 y la esclerosis múltiple son dos ejemplos de este tipo de enfermedad. Las 
infecciones víricas se han relacionado con el desarrollo de la esclerosis múltiple y la 
diabetes tipo 1, pero otros factores también pueden ser parcialmente responsables. De 
hecho, las interacciones y la diferente contribución de estos factores pueden finalmente 
provocar estas enfermedades. En conclusión, las evidencias han mostrado la asociación 
entre infección viral y enfermedades autoinmunes, pero es necesaria más investigación. 
Palabras clave 
Enfermedades autoinmunes, factor ambiental, infección vírica, virus, diabetes tipo 1, 
esclerosis múltiple 
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Resumo 
As enfermidades autoinmunes son desordes causados por erros na función do sistema 
inmunitario.  A predisposición xenética, os factores ambientais e o estilo de vida 
consideránse como os factores que poden desencadear o desenvolvemento destas 
enfermidades. Entre os factores ambientais, os virus son unha das causas máis 
importantes e estudadas que poden levar ás enfermidades autoinmunes. Con todo, 
aínda que a relación pode ser clara, os mecanismos subxacentes ás infeccións víricas 
que contribúen á progresión da enfermidade aínda non se comprenden ben. Algunhas 
teorías suxeríronse, pero máis experimentación é necesaria para que poidan ser 
aceptadas pola comunidade científica. A diabetes tipo 1 e a esclerose múltiple son dous 
exemplos deste tipo de enfermidade. As infeccións víricas poden estar asociadas ao 
desenvolvemento de esclerose múltiple e diabetes tipo 1, pero outros factores tamén son 
parcialmente responsables. De feito, as interaccións e os distintos grados de 
contribución destes factores poden, finalmente, provocar a enfermidade. En conclusión, 
as evidencias amosan a existente asociación entre infección viral e enfermidades 
autoinmunes, pero é necesaria máis investigación. 
Palabras clave 
Enfermidades autoinmunes, factor ambiental, infección vírica, virus, diabetes tipo 1, 
esclerose múltiple 
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1. Introduction 
Autoimmune diseases are disorders caused by a malfunction of the immune system since 
the organism does not recognise and attacks its own cells (Jose et al., 2014; Page et al., 
2011; Smith and Germolec, 1999). The causes beyond these diseases are still unknown 
in multiple cases, although some general mechanisms can be involved to trigger 
autoimmunity such as genetics, environment or even previous viral or bacterial infections 
(Delogu et al., 2011). It is also known that the pathogenesis is not only due to one factor 
but to different combining factors.   
These diseases can have different symptoms and may affect any organ, therefore the 
amount of this type of conditions is very high, existing more than eighty types of 
autoimmune diseases (Ercolini and Miller, 2009; Jose et al., 2014; Page et al., 2011). 
Some examples are multiple sclerosis, autoimmune hepatitis, diabetes mellitus type I, 
rheumatoid arthritis and autoimmune pancreatitis.  
The presence of some genes may increase the probability of having an autoimmune 
disease, triggered by the environment. These genes may control different processes 
affecting the roles of T and B lymphocytes, important cells in immunity (Jose et al., 2014). 
Moreover, molecular mimicry and microbial agents are also mechanisms leading 
autoimmunity.  
Concerning infections in autoimmune diseases, microbial agents may lead to 
autoimmunity in different situations. It may happen that the pathogen has similar 
elements of a self-antigen, it is the called molecular mimicry. The immune cells do not 
distinguish the antigen from the pathogen damaging the organism. Epitope spreading 
(epitope is the part of an antigen recognised by the immune system), bystander activation 
and cryptic antigens are also involved in microbial autoimmunity. One reason or another, 
these different mechanisms activate parts of the immune system, therefore ultimately 
activating the self-immune response (Ercolini and Miller, 2009). 
Scientists discovered the existence of autoimmune diseases during mid-20th century. At 
first, they were not understood due to the unknow process of how immune system can 
distinguish self-antigen from foreign elements (Margo and Harman, 2016). With the 
medicine advances, researchers could answer this question and investigate better 
autoimmune diseases (Rose, 2016). However, these discoveries occurred quite late in 
the 20th century (Wong, 2015).  
Nowadays, autoimmune diseases are becoming to be more important as the incidence 
and prevalence are increasing in industrialized countries (Rose, 2016). However, the 
experimental studies and investigation remains low as the costs are elevated and the 
results are not always positive (Moccia et al., 2017).  
Physical exercises and physiotherapy may be some medical actions to help patients in 
some diseases (Page et al., 2011). However, it is not enough. Ideal medicines or 
prevention techniques have not been discovered yet, or even, palliative medicines are 
still in experimental processes leading to unsafe and ineffective trials. Anyway, finding 
proper treatments is hard due to the high quantity of autoimmune diseases, the distinct 
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symptoms that may occur and the late apparent diagnosis (Rose, 2016). The unknown 
precise cause of autoimmunity makes even more difficult reducing these cases. So, 
repair or decrease damage is the objective of researchers to improve patient’s lives 
(Rose, 2016).  
The aim of this review is to recap and illustrate the main aspects of the viral infections 
which lead to autoimmune diseases. On the other hand, highlighting the impact of these 
diseases and the importance of the role of some pathogens, such as viruses, is also 
desired. Therefore, the latest objective is to encourage investigating these disorders 
since people have becoming more affected by this kind of illness. In order to summarize 
different reviews and articles, searching in PubMed and Scopus has been carried out with 
the search terms, alone or combined: “autoimmune diseases”, “viral”, “virus”, 
“autoimmunity”.  
First, the mechanisms of viral infection and molecular mimicry would be explained, as it is 
fundamental to study them to better understand the resulting autoimmune diseases. Its 
study is also helpful to find different methods against viral autoimmune diseases. 
Moreover, some important examples of autoimmune diseases are going to be discussed, 
as well as the importance of several viruses that will trigger autoimmunity. 
2. Current Perspectives 
 
We are surrounded for lots of diseases that affect our lives directly or indirectly. Some of 
them are autoimmune diseases whose rising effects and incidence are deteriorating 
population wellness and health, becoming a significant issue for society. As the causes of 
these diseases are not well known, it is required to increase the number of studies and 
investigations (Rose, 2016). In addition, viral infections would trigger more cases of 
autoimmune diseases.  
Viral infections arise commonly among all populations, and some evidences indicate that 
viruses may be responsible of different autoimmune diseases (Correale and Gaitán, 
2015; Libbey et al., 2014). Sometimes these infections may trigger altered immune 
responses causing attacks against viral and self-elements, and finally autoimmunity 
(Getts et al., 2013). It has been proved that cases of autoimmune diseases have higher 
presence of infections than in normal population (Libbey et al., 2014).   
The impact of autoimmune diseases is increasing as the incidence and prevalence are 
becoming higher. It is thought that this kind of diseases are not common, but the effects 
are quite important (Wang et al., 2015). The incidence is rising quickly, resulting in new 
cases, more in women than in men (Page et al., 2011). The global prevalence of 
autoimmunity is around 5 % (Wang et al., 2015).  
As autoimmune diseases include high burden of mortality, it can be a major concern 
among people (Wang et al., 2015). In a study, the relevance of a famous actor death by 
an autoimmune disease has been recorded; this fact increased the searches at web 
browsers and some social networks, with high results of autoimmune disorders and 
vasculitis searches and trends. Therefore, autoimmune diseases news affected 
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population and increased their curiosity, leading to look for more information. This 
explains that when there are famous examples of an autoimmune disease, society is 
more aware about it (Bragazzi et al., 2016).  
For instance, it has been tested that patients with HIV may present more probabilities of 
suffer an autoimmune disease (Yen et al., 2017). 
Furthermore, it has been shown that incidence of autoimmune hepatitis is higher than 
thought, affecting all races and ages, being more present in women (Primo et al., 2009), 
and it is related to other diseases (Aizawa and Hokari, 2017). But, antiviral drugs might 
eliminate autoimmune hepatitis (Aizawa and Hokari, 2017).   
Diabetes mellitus type 1 prevalence is high in South Spain, that may lead to a concerning 
morbidity and mortality. Comparing with previous data, diabetes prevalence is greater 
than in other parts of Europe and it can be linked to obesity prevalence (Soriguer-Escofet 
et al., 2002). 
Regarding multiple sclerosis, the global prevalence is 33 per 100,000 people, but it 
depends on the geography (Vidal-Jordana and Montalban, 2017). In Western countries, it 
has a relevant impact and costs that may decrease with knowledge. So, investigation has 
been done even the costs are quite elevated. However, the evolution of new techniques 
and new materials can decrease the costs, leading to more investigation and more 
treatments (Moccia et al., 2016). Canada is the country with the highest rate of multiple 
sclerosis, with 291 cases per 100,000 people, almost 10 times more than the global 
mean (Brown, 2016).  
Therefore, the incidence and prevalence varies depending on the disease.  Age, gender, 
ethinicity, geography… also have a role in the epidemiology (Wang et al., 2015). 
 
3. Virus and autoimmune diseases 
It has been confirmed that different pathogens may lead to autoimmune disease, 
activating or spreading self-immune responses (Ercolini and Miller, 2009; Steed and 
Stappenbeck, 2014). They induce this kind of illness mainly by molecular mimicry. 
Moreover, the activation of the immune response can be triggered by epitope spreading 
or bystander activation (Delogu et al., 2011; Molina and Shoenfeld, 2005). Some 
significant microorganisms behind autoimmunity, being a primary factor, are viruses, 
some of them well studied and known (Steed and Stappenbeck, 2014). However, the 
clear interactions vary depending on the disease and more information is still needed 
(Ercolini and Miller, 2009; Steed and Stappenbeck, 2014).  
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3.1 Role of viruses 
Viruses can break tolerance to self and trigger autodestruction events of tissue or a 
complete organ (von Herrath et al., 1998). Immune tolerance is the process of 
unresponsiveness to elements that may induce immune responses. So, the immune 
system can distinguish non-pathogenic microbes or self-antigens from pathogens. This 
may lead to a good self-defence (Steed and Stappenbeck, 2014). Therefore, the 
breakdown of the immune tolerance will result in attacks to viral and self-antigens and 
their elimination (Getts et al., 2013).  
The mechanisms leading to autoimmune diseases by virus are: molecular mimicry, 
bystander activation, epitope spreading and viral persistence (Delogu et al., 2011; 
Ercolini and Miller, 2009; Fujinami et al., 2006; Getts et al., 2013). The interaction 
between the virus and the host should be considered since some viruses create 
persistent and latent infections. Therefore, it would be essential to find out when viral 
cycle leads to autoimmunity (Steed and Stappenbeck, 2014).  
Molecular mimicry refers to an immunologic shared epitope between a host and a 
microbe. So, the microbe may have proteins with amino acid sequences or structure 
homologues in humans (Ercolini and Miller, 2009; Getts et al., 2013; Trela et al., 2016). 
Since the microbe may carry similar elements, the activated T cells (cell that controls the 
immune responses) react against self-antigens causing damages and the activation of 
further immune responses, this process is called cross-reaction (Delogu et al., 2011; 
Fujinami et al., 2006).  
Concerning viruses, these pathogens can have cross reactive epitopes with host self-
proteins. Monoclonal antibodies have been shown cross-reactivity with host proteins in 
different studies and diseases. Moreover, viruses also activate epitopes, presented to 
antigen-presenting cells, contributing to the development of autoimmune diseases 
(Fujinami et al., 2006; Trela et al., 2016;).  Some viral models have been studied and 
therefore needed to explain the mechanisms of acquired autoimmunity via molecular 
mimicry. It also has been determined that T cells with low affinity for a self-antigen may 
initiate molecular mimicry because of viral infections (Getts et al., 2013). However, not all 
similar peptides of humans and microbes will lead to autoimmunity, as they stay inert, not 
causing molecular mimicry (Trela et al., 2016). 
Bystander killing has become more relevant thanks to animal models experiments 
confirming this mechanism. Viral infections contribute to trigger APC (antigen presenting 
cells), which can activate autoreactive T cells. Finally, this will lead to an autoimmune 
disease (Fujinami et al., 2006). Viruses may initiate bystander activation, too.  So, 
bystander T-cell activation might be caused by the presentation of antigens to aberrant 
autoreactive T-cells. Even if those T-cells have low affinity for self-antigen, they are 
indeed activated by the viral infection (Getts et al., 2013).  
In relation with this mechanism, epitope spreading contributes to the activation of an 
immune response due to viral infections leading to the delivery of self-antigens and de 
novo activation of autoreactive responses (Getts et al., 2013).  
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The immune response spreads and creates more responses against parts of the same 
protein or a different one. In animal models, it has been seen that dominant epitopes 
bring out the first responses (Delogu et al., 2011). 
Other mechanism is the persistence of viral infections, as the latent constant of viral 
antigen may activate the immune response any time. Moreover, antiviral antibodies or 
presentation of cryptic antigens may have importance in the autoimmunity development, 
thus, initiating an autoimmune disease (Delogu et al., 2011; Fujinami et al., 2006).  
 
Figure 1: Mechanisms of induced autoimmunity by microbe infections (Ercolini and Miller, 2009)  
Then, these mechanisms will contribute in many and different ways to the evolution of 
autoimmunity, but the process behind is still unknown. It is possible that variations are 
due to the different viral infections and type of viruses (Getts et al., 2013). In addition, 
microbe triggers of autoimmunity are hard to identify because the apparent clinical 
responses need time to be detected (Delogu et al., 2011).  
Autoreactive T-cells and infections are required to initiate the progression of an 
autoimmune disease (Delogu et al., 2011).  
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3.2 Example: Epstein-Barr virus 
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus and a very well-studied virus. It can 
cause latent infections and it has a role in several autoimmune diseases as lupus, 
rheumatoid arthritis or multiple sclerosis. In patients with systemic autoimmune disorders, 
there are a presence of high loads of the virus, altered specific T-cells and antibodies 
against EBV (Fujiwara and Takei, 2015; Steed and Stappenbeck, 2014). EBV is a 
needed factor for the progress of multiple sclerosis. It has been shown that one 
mechanism that leads to autoimmune diseases, due to EBV infections, is molecular 
mimicry between EBV proteins and self-proteins (Tousirot and Roudier, 2008).   
 
Figure 2: Drawing of EVB and its target cells (Draborg et al.,2013) 
However, there are more mechanisms that explain the induction of autoimmunity by EBV 
infection. EBV infects several lymphocytes, and induces the immune response to evade 
and supress apoptosis of those infected lymphocytes. These processes may cause 
tolerance breakdown and, lately, autoimmunity (Draborg et al., 2013).  
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4. Virus and multiple sclerosis 
Multiple sclerosis (MS) is a human inflammatory disease of the central nervous system 
where demyelinating occurs (Croxford et al., 2005; Libbey et al., 2014). MS is a rare 
disorder mediated by autoreactive T-cells (Croxford et al., 2005; Brown, 2016). However, 
the causes underlie MS are quite common and are being studied. The main factor leading 
to MS are genetic background and environmental factors as Epstein-Barr virus, low levels 
of vitamin D, smoking or even obesity (Brown, 2016; Correale and Gaitán, 2015; Libbey 
et al., 2014; Mostafa et al. 2017; Olsson et al., 2017). The combination of these elements 
contributing to MS is clear, but the possible interactions between them to trigger MS 
remain unknown (Brown, 2016; Correale and Gaitán, 2015). 
Genes only explain a small part of the propensity to develop MS. The main genetic risk 
factor consists of human leukocyte antigen complex (HLA). There are also other 
molecules and loci involved, like T-cell receptors or non-HLA genomic regions (Brown, 
2016; Correale and Gaitán, 2015; Libbey et al., 2014; Olsson et al., 2017). However, the 
environmental factor o epigenetics may change gene expression altering some immune 
pathways that ultimately lead to MS. Thus, genes alone do not cause MS, in fact, their 
contribution is low (Brown, 2016; Correale and Gaitán, 2015; Jörg et al., 2016). 
 
Figure 3: Causes that trigger autoimmune diseases (Schmidt, 2016)  
During MS development, oligodendrocytes from the central nervous system are 
considered the main target cells, as autoimmune T cells (helpers) destroy them stopping 
myelin production. Other types of T cells are also important for demyelination (Mentis et 
al., 2017).  
Clinically, MS has become a major concern as the prevalence has increased around 10 
times in the last years. Incidence is growing as well as the patients’ survival explaining 
the increased levels. Because of that, health care has also improved to treat this disease. 
However, inequity has been seen so, more investigation and funding is needed (Browne 
et al., 2013; Mentis et al., 2017). 
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4.1 Environmental factors 
Several studies have concluded that the main factors initiating MS development are 
pathogen infections, low vitamin D or lifestyle habits (smoking, diet). MS has a clear 
geographical distribution due to the probable effect of lower quantity of vitamin D on 
people. However, this link and how vitamin D influences continue being unknown (Brown, 
2016; Correale and Gaitán, 2015).  
Vitamin D has a major role in calcium homeostasis regulation and it is important for 
immune and inflammation regulation. Vitamin D may influence in several autoimmune 
diseases (Correale and Gaitán, 2015). So, vitamin D is an immunoregulator of some cells 
as T cells, being able to activate these cells but also inhibiting different transcription 
factors (Correale and Gaitán, 2015). Other immune cells influenced by vitamin D are the 
B cells (lymphocytes whose function is the antibodies production), decreasing antibody 
production with lower vitamin D levels.  
Researchers have been trying to demonstrate the impact of vitamin D in the development 
of MS, discovering that low levels of vitamin D may be a risk as well as genetic 
background (Brown, 2016). Thus, the MS risk is less when there is more sunlight 
exposure or vitamin D supplements ingestion (Correale and Gaitán, 2015). In some 
experiments, vitamin D and a derivative have been used as protective elements for 
immunity.  
However, other studies showed that risk genes can also be affected by vitamin D levels 
causing mutations and vitamin D may interact with HLA loci increasing MS risk. Vitamin D 
interacts with the vitamin D receptor present in immune cells, these effects combining 
allelic variations determine MS risk (Correale and Gaitán, 2015). 
In addition, infections also may influence the development of MS. Pathogenic agents like 
bacteria, viruses or parasites may have an important role, not only as risk factor but also 
as protective agents (Libbey et al., 2014). This idea is supported by the hygiene 
hypothesis, which explains that exposure at early age to harmless, infectious agents 
protect against MS (Correale and Gaitán, 2015; Jörg et al., 2016; Libbey et al., 2014). 
But, an exposure at later life may increase the MS risk (Libbey et al., 2014). Therefore, 
there is a correlation between high risk of MS and a high sanitation during early life 
(Correale and Gaitán, 2015).  
For example, the nematode parasite Trichuris trichiura appearance seems to decrease 
MS global prevalence. In some way, this parasite induces some protection against MS. In 
fact, in poor countries limited sanitary conditions and high parasites predominance 
contribute to low levels of allergic and autoimmune diseases (Correale and Gaitán, 2015). 
On the other hand, some recent studies have been carried out in developing countries. 
They found an increase of MS prevalence due to the lower cases of infections. Animal 
model experiments also demonstrate these hypotheses (Correale and Gaitán, 2015; 
Libbey et al., 2014).  
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Thus, considering these ideas and discoveries, the risky group to develop Ms is mainly 
predisposed young adults affected by multiple infections, living in good sanitary 
conditions (Correale and Gaitán, 2015, Libbey et al., 2014).  
Despite the evidences that pathogens may have a role in MS process, their acceptance 
as main factors have not been accomplished yet (Libbey et al., 2014). There are so many 
potential influences (genetic make-up, environment, nutrition and lifestyle habits) that is 
not possible to identify one pathogen as MS cause. Smoking, obesity, UV exposure and 
pathogen infections interact affecting adaptive or innate immunity, leading to MS (Libbey 
et al., 2014; Olsson et al., 2017). 
4.2 Viral agents 
Viruses are a type of pathogens also responsible of MS aetiology. Two hypothesis may 
explain why a virus might cause MS development. One, only an agent leads to MS with a 
rare expression of a frequent virus or a common expression of a rare virus. The second 
one is called competing hypothesis where several agents disturb different pathways 
contributing MS (Mentis et al., 2017).  
There are several mechanisms through virus may origin demyelination, elimination of 
myelin and axonal deterioration (Libbey et al., 2014; Mentis et al., 2017). In these 
mechanisms lysis of oligodendrocytes (infected or unaffected) takes place, but it can be 
done by the virus, by the host immune system, by nonspecific bystander immune 
response or by self-reactive immune response. The immune responses are triggered by 
the viral infection (Libbey et al., 2014; Mentis et al., 2017). Several researches have 
explained the possible link between viruses and MS, being rabies virus the first one 
discovered. Now, the best considered as causal factor are herpes viruses and human 
endogenous retroviruses (Libbey et al., 2014). 
Some viral mechanisms can be responsible of the immunology of MS: molecular mimicry, 
bystander activation, epitope spreading, fertile field, and viral “déjà vu” (Mentis et al., 
2017). 
Some studies showed that molecular mimicry epitopes activate immune responses and 
trigger different autoimmune diseases. So, the similarity of viral proteins and human 
proteins stimulate autoreactive T cells leading to autoimmunity (Olson et al., 2001). This 
mechanism has also an important role in MS since molecular mimicry induces 
autoreactive T cells, so activation of an inflammatory response attacks central nervous 
system (CNS) myelin (Croxford et al., 2005; Mentis et al., 2017). Nevertheless, the direct 
association between mimicry activated autoimmunity and viral agents has not been 
proved. Some viral infections may increase the number of altered T cells by molecular 
mimicry, but the mimic epitopes from virus still need to be investigated. Thus, some 
evidences that virus molecular mimicry enhance MS have been recorded (Croxford et al., 
2005).  
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In bystander activation, viral elements and receptors induce self-proteins presentation to 
dendritic cells to finally create autoreactive T cells. These T cells would trigger 
inflammation and cell death (Grigoriadis and Hadjigeorgiou, 2006; Mentis et al., 2017).  
Epitope spreading may induce T and B cell-mediated responses. Viral peptides activate 
macrophages eliminating neuronal myelin (Grigoriadis and Hadjigeorgiou, 2006; Mentis 
et al. 2017).  
In fertile field theory, a transient, short-lived state (fertile field) is due to a viral infection. 
An initial inflammatory response by a viral infection produces autoreactive T cells via 
other mechanisms previously activated leading to neuronal inflammation. This fertile field 
depends on the type of virus, location and response (Libbey et al., 2014; Mentis et al., 
2017).  
The last theory, viral “déjà vu”, explains that a viral infection would create T cell clones 
which are going to be reactivated by other viruses, so finally causing neuronal 
inflammation (Mentis et al., 2017).  
 
Figure 4: Mechanisms underlying viral aetiology to cause multiple sclerosis (Mentis et al., 2017)  
4.3 Epstein-Barr Virus  
The strongest association of a virus and MS seems to be the influence of Epstein-Barr 
virus. This virus may not cause symptoms in so a big part of the population and therefore 
it is usually undiagnosed. However, this virus has a high persistence and a global high 
exposure (Brown, 2016; Correale and Gaitán, 2015). Some studies showed that several 
patients with MS are EBV seropositive. These MS patients have high number of anti-EBV 
Patricia Priegue Piñeiro 
13 
 
antibodies than healthy people. So, it demonstrates that EBV may be a factor inducing 
MS (Jörg et al., 2016).  
There exist different theories to explain how EBV infection may culminate in MS, but more 
investigation is needed to better understand those possible mechanisms (Correale and 
Gaitán, 2015). One theory is based on the central nervous system infection by EBV. So, 
oligodendrocytes are killed and, therefore, there is no longer myelin production, 
damaging nerve function.  Moreover, the virus also can induce an immune response that 
will kill the virus and it also will attack oligodendrocytes and neurons. Some studies 
showed viral presence in the CNS, but others did not have the same success (Brown, 
2016).  
The second hypothesis maintains that molecular mimicry may cause indistinguishable 
selection of myelin proteins and viral proteins, leading to disrupted myelination. Then, T 
cells are activated, because of the response against the virus, and start attacking viral 
and myelin proteins (Brown, 2016). There are evidences proving these theory as specific 
T-cell antigens have been found (Correale and Gaitán, 2015). 
The third mechanism implicates another type of immune cells, the called B cells. When 
they are overactivated due to the viral infection the immune response continues 
spreading. As the immune cascades are not reversing, body cells are also injured. EBV 
induces B cells and T cells imbalance damaging their regulatory functions. Finally, these 
B cells trigger damages on the self-cells (Brown, 2016). In addition, after infection, B cells 
would be able to avoid apoptosis promoting CNS inflammation (Correale and Gaitán, 
2015). 
Moreover, since T cells have been altered by the viral infection, antibody production 
decreases. Therefore, virus may remain in the body forcing the immune system to 
continue working and still promoting loss of tolerance (Correale and Gaitán, 2015).  
5. Virus and diabetes 
Type 1 Diabetes mellitus (T1D) is an autoimmune disease where autoreactive T cells and 
inflammatory cytokines induce the pancreatic cells destruction. Therefore, this destruction 
leads to insulin loss (Jun and Yoon, 2001; Katsarou et al., 2017; Rodriguez-Calvo et al., 
2016). The aetiology of this disease needs more investigation since some aspects are not 
well known. However, researchers have concreted that genetic and environmental factors 
(viruses or other pathogens) may influence autoimmune diabetes development (Jun and 
Yoon, 2001; Katsarou et al., 2017; Kondrashova and Hyöti, 2014; Rodriguez-Calvo et al., 
2016).   
Nowadays, around 15 million of people suffers this disease whose development usually 
starts during childhood or teenage. Its prevalence and incidence have been increased 
and more cases in the future are being expected. These increases may be the result of 
environmental factors. Therefore, studying and understanding the causes underlie 
diabetes, it would be helpful to prevent and achieve early diagnosis (Kondrashova and 
Hyöti, 2014). 
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Type 1 diabetes may result from complex genetic make-up, but it seems not to be any 
obvious inheritance patterns. However, the risk of getting T1D is higher when relatives 
also have it. More than 60 risk genes have been found and one main loci involved is HLA, 
also partly responsible of other autoimmune diseases such as MS (Coppieters et al., 
2012; Regnell and Lenmark, 2017).  
HLA play an important role as they are necessary to the adaptive immune system. 
Alterations in its heterodimers would trigger responses against proinsulin as well as 
against other essential proteins. So, these loci may influence the aetiology and 
pathogenesis of T1D (Regnell and Lenmark, 2017).  
Some environmental factors may interact with the predispose genes, such as vitamin D, 
bacteria, or viral infections (Coppieters et al., 2012; Regnell and Lenmark, 2017).  
5.1 Environmental factors 
T1D may be resulted by environmental factors, as they can induce beta cell autoimmunity 
(cell in the pancreatic islets of the pancreas). It seems clear that high T1D prevalence 
may result from environmental impact since human genetics changes are not quick 
enough to reflect the rapid rises of the disease (Drescher et al., 2015). 
Pathogen infections are the most studied factors and many experiments have been done 
to prove its association with T1D (Regnell and Lenmark, 2017). These microbial 
infections have been suggested as a major regulator of TD1 risk. Two hypothesis may 
explain their importance: hygiene hypothesis considering that microbial exposure during 
early life may protect against T1D; the second theory, called triggering hypothesis, 
explains that a microbe produces beta cells damage (directly or via immune-controlled 
mechanisms) inducing T1D (Kondrashova and Hyöti, 2014).  
Most microbial studies found that viral infections may be part of the risk factors, but also 
can have protective functions, whereas bacteria contribute to protection against T1D and 
other autoimmune diseases (Kondrashova and Hyöti, 2014). Some studies also suggest 
that gut microbiota may be associated with T1D. Intestinal microbiota play a crucial role in 
human health, so their possible importance in T1D relationship is not a surprise. Some 
studies confirmed that indeed there is an association between gut microbiota and T1D, 
but it is being investigated in animal and human models. Due to diet and environmental 
factors this microbiota may change resulting in normal or altered immune responses. 
Thus, microbiota modulation may trigger T1D. When this situation happens, T1D patients 
present different gut microbiota composition comparing to healthy individuals (Bibbò et 
al., 2016).  
Moreover, nutrition might regulate the T1D risk. For example, cow´s milk may contribute 
the progress of beta cell autoimmunity besides T1D development in children.  Other 
studies suggest that diet in early life may also have an impact in the risk of this disease 
(Regnell and Lenmark, 2017).  
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More discoveries maintain that vitamin D may have a protection role against type 1 
diabetes due to its ability of regulating the immune system. Also, fatty acids may influence 
the risk of autoimmunity. However, more clinical experiments are needed to prove these 
suggested associations. Sugar ingest, puberty, trauma or obesity have been also studied 
and linked to beta cell stress, thus finally leading to autoimmunity (Regnell and Lenmark, 
2017). 
In addition, some studies tested that psychosocial factors might be involved in T1D 
development. For example, stress can be a potential inducer but more investigation is 
needed to confirm this possible trigger (Teddy study group, 2008). Diet, stress or risk 
genes may interact contributing to the appearance of T1D.  
5.2 Viral agents 
Viral infections are well studied and seem to be one factor triggering type 1 diabetes 
(Kondrashova and Hyöti, 2014). A high number of viruses have been related with T1D, 
being enterovirus the main group suggested. For example, some studies showed that 
enterovirus more commonly infect diabetes patients. Moreover, a link between 
predisposed HLA genes and enterovirus infection has been discovered (Filippi and von 
Herrath, 2015).  
Different arguments justify viral infections and T1D association: T1D can be classified as 
a seasonal disease and this type of diseases usually result from viral infections; most 
T1D patients produce specific viral antigens (Jun and Yoon, 2001).  
These enteroviruses can induce T1D via different mechanisms, but more research is 
needed to prove them. The viral infection may enhance inflammation in the islets, due to 
T-cell cross reactivity, as well as the possible lysis of beta cells (Kondrashova and Hyöti, 
2014; Filippi and von Herrath, 2015). However, the viral effects are different from 
expected. Enterovirus would be also able to create an autoimmune attack to the 
pancreatic islets. Anyway, as the mechanism are not totally understood and some 
discoveries are not enough clear, it is necessary more investigation (Filippi and von 
Herrath, 2015).  
Other theories about the viral infection mechanisms suggest that viruses can interfere T-
cell selection, interfering with T-cell maturation. Bystander activation, molecular mimicry 
or virus persistence are also some hypothesis to explain T1D and virus relationship 
(Coppieters et al., 2012). 
To prevent from T1D triggered by enteroviruses infection, vaccination could be a strategy. 
Some reports support these ideas. Nevertheless, there are also contradictions as in poor 
countries T1D incidence is lower than in richer countries, but poor countries present 
higher levels of infections. In addition, the hygiene hypothesis explains that some 
pathogens may act as protective agents against T1D risk (Filippi and von Herrath, 2015). 
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Table 1: Viruses related to the development of Type 1 diabetes (adapted from Jun and Yoon, 2001) 
Virus Host Evidence 
Coxsackie B Mice; primates; humans Virus identified; possible 
destruction of beta cells 
Cytomegalovirus Humans Association with T1D 
Encephalomyocarditis Mice; hamsters Cytolytic destruction of beta 
cells 
Epstein-Barr Humans Possible induction of T1D 
Rubella Hamsters; rabbits; humans Possible association with T1D 
Varicella zoster Humans Indirect association with T1D 
 
5.3 Coxsackie B Virus 
CVB (Coxsackie B virus) is a group of positive ssRNA viruses, belonging to enterovirus 
genus. These viruses can infect humans with low or none symptoms like cold-like 
manifestations.  CVB has been well studied, and related to numerous human diseases 
(Tracy et al., 2002). As CVB has been detected in type 1 diabetes patients, it is 
considered as a viral factor which triggers this disease (Sané et al., 2011). T1D patients’ 
blood usually contain CVB RNA as well as high amounts of CVB antigens proving this 
hypothesis (Filippi and von Herrath, 2015). However, the aetiology role of CVB has not 
been demonstrated yet as this infection may only occur in a small population (Filippi and 
von Herrath, 2015; Tracy et al., 2002).  
The mechanisms behind CVB and T1D relationship remain unclear, but some general 
theories have been suggested. To explain T1D underlying mechanisms several in vitro 
studies have been done as well as animal models usage. CVB may lead to T1D by beta 
cell lysis, bystander activation, viral persistence, molecular mimicry, antibody 
enhancement and thymus function disturbance and antibody enhancement (Sané et al., 
2011).  
Some studies revealed that CVB infection might accelerate T1D development. 
Nevertheless, in a specific experiment they could not prove CVB aetiology in T1D. 
However, they found that in early-life mice CVB infection play a protective role, 
decreasing T1D risk. The mechanism underlying these effects is still unknown (Tracy et 
al., 2002). 
To conclude, the results of different experiments (in vitro and in animal models) may 
support the theories of the importance of CVB in T1D. Despite the success, more 
investigation is required to achieve a better understanding of the mechanisms and a 
future creation of treatments (Sané et al., 2011).  
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6. Conclusions/Conclusiones/Conclusións 
 
Conclusions 
Autoimmune diseases are due to a defect of the immune system as self-cells are being 
attacked by the organism. The symptoms are very variable that is why more than eighty 
different autoimmune diseases coexist.  
These diseases have become a big concern due to their incidence and prevalence 
increase. Therefore, investigation has been realised to try to understand the mechanisms 
and causes behind these disorders.  
Genetics, environmental factors and lifestyle habits may trigger the development of 
autoimmune diseases. Viral infections have been demonstrated to play a major role in the 
trigger of these diseases or at least increasing the development risk. The mechanisms 
underlying the diseases by viral infections go from molecular mimicry, bystander 
activation or epitope spreading, ultimately leading to autoimmunity. Therefore, viruses 
are, in fact, associated in one way or another to autoimmune diseases.  
Multiple sclerosis and type 1 diabetes are two examples of autoimmune diseases. Viral 
infections have been suggested and proved to trigger MS and T1D via different 
mechanisms still being unclear. However, there are different hypothesis explaining the 
role of viral infections in the development of these diseases as well as the hypothesis that 
pathogens and viruses may also play a protective role. Other factors as genetic 
predisposition, diet, lifestyle habits or vitamin D levels may also trigger these diseases. 
To sum up, there are evidences concluding virus and autoimmune diseases are 
associated. However, to explain this relationship and the mechanisms behind, more 
investigation is needed. For instance, experiments with virus and animal models can be 
done to prove the hygiene hypothesis and try to take advantage of their protective role 
using them as prevention treatments. 
Conclusiones 
Las enfermedades autoinmunes se deben a un mal funcionamiento del sistema 
inmunológico, ya que las propias células son atacadas por el organismo. Como existen 
más de ochenta enfermedades autoinmunes diferentes, los síntomas son muy variables 
y, por tanto, dependen de la enfermedad en cada caso. 
Estas enfermedades se han convertido en una gran preocupación debido al aumento de 
su incidencia y de su prevalencia. Por lo tanto, se ha empezado a realizar múltiples 
investigaciones para intentar comprender los mecanismos y causas detrás de estos 
trastornos. 
La genética, los factores ambientales y los hábitos de vida pueden desencadenar el 
desarrollo de enfermedades autoinmunes. Se ha demostrado que las infecciones víricas 
desempeñan un papel importante en el desarrollo de estas enfermedades o al menos 
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parecen aumentar el riesgo de su desarrollo. Los mecanismos que pueden 
desencadenar estas enfermedades por infecciones víricas van desde el mimetismo 
molecular, la activación inespecífica o la propagación de epítopos, que finalmente 
conduce a la autoinmunidad. Por lo tanto, los virus están, de hecho, asociados de una 
manera u otra a enfermedades autoinmunes. 
La esclerosis múltiple y la diabetes tipo 1 son dos ejemplos de enfermedades 
autoinmunes.  Se han sugerido y demostrado que las infecciones virales pueden ser 
desencadenantes de esclerosis múltiple y de diabetes tipo 1 a través de diferentes 
mecanismos aún no claros. Sin embargo, hay diferentes hipótesis que explican el papel 
de las infecciones virales en el desarrollo de estas enfermedades, así como la hipótesis 
de que los patógenos y los virus también pueden desempeñar un papel protector. Otros 
factores como predisposición genética, dieta, hábitos de vida o niveles de vitamina D 
pueden también causar estas enfermedades. 
Hay evidencias que concluyen que virus y enfermedades autoinmunes están asociados. 
Sin embargo, es necesaria más investigación para explicar esta relación y los 
mecanismos subyacentes. Por ejemplo, se podrían realizar más experimentos con virus 
y animales para demostrar la hipótesis de la higiene y así, aprovechar sus propiedades 
protectoras usándolos como tratamientos preventivos. 
Conclusións 
As enfermidades autoinmunes son causadas por unha mal función do sistema inmune, 
porque as propias  células  son atacadas polo organismo. Ao existir máis de oitenta 
enfermidades autoinmunes diferentes, os síntomas varían amplamente dependendo da 
enfermidade.  
Estas enfermidades tornáronse unha gran preocupación pola súa crecente incidencia e 
prevalencia crecente. Polo tanto, empezaron a realizarse múltiples investigacións para 
tratar de entender os mecanismos e causas detrás destes trastornos. 
Xenética, factores ambientais e hábitos de vida poden desencadear o desenvolvemento 
de enfermidades autoinmunes. Suxeriuse que as infeccións virais poden actuar como 
factores con papeis importantes no desencadeamento de estas enfermidades ou polo 
menos aumentando o risco do seu desenvolvemento. Os mecanismos subxacentes á 
enfermidade por infeccións víricas varían dende mimetismo molecular, a activación non 
específica ou  a extensión de epítopos, que finalmente conduce á autoinmunidade. Así, 
os virus están, de feito, asociados, dunha forma ou outra, ás enfermidades autoinmunes. 
A esclerose múltiple e a diabetes tipo 1 son dous exemplos de enfermidades 
autoinmunes. Demostrouse que as infeccións virais son factores que poden provocar 
esclerose múltiple e diabetes tipo 1 a través de diferentes mecanismos aínda non claros. 
Sen embargo, hai diferentes hipóteses para explicar o papel das infeccións virais no 
desenvolvemento destas enfermidades, así como a suposición de que patóxenos e virus 
poden presentar un papel protector. Outros factores, tales como  a predisposición 
xenética, alimentación, estilo de vida ou niveis de vitamina D poden inducir o 
desenvolvemento de estas enfermidades. 
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Hai evidencias que conclúen que virus e enfermidades autoinmunes están relacionadas. 
Sen embargo, máis investigación é necesaria para explicar esta relación e os 
mecanismos subxacentes. Por exemplo, deberían realizarse máis experimentos con 
virus e animais poderían para demostrar a hipótese da hixiene e así, aproveitar as súas 
propiedades protectoras usándoos como tratamentos preventivos 
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